drugset / Trial / NCT00781352

Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study

NCT00781352

Phase 3 Completed 408 enrolled The Cleveland Clinic
RandomizedParallel-groupDouble-blindPrevention

Summary

This study was developed to test the hypothesis that the risk of colorectal cancer recurrence was similar in patients who were randomly assigned to 65% nitrous oxide or nitrogen during colorectal surgery.

Timeline

Start
1998-11
Primary completion
2003-11
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitrous Oxide Other / unclassified 65 %
Comparator nitrogen Unknown

Indications